Polyphenol diet trial opens recruitment for cardiometabolic health study — LiveFuture News
Open on LiveFuture.ai →

Polyphenol diet trial opens recruitment for cardiometabolic health study

A University of Parma registry study is recruiting for a randomized trial testing a polyphenol-rich diet, personalized dietary plans, and cardiovascular risk measures in adults across two age ranges.

A new registry entry shows a randomized study now recruiting for Precision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)Phenols. The study is listed as overall_status RECRUITING, with no posted results yet, so this is a live research effort rather than a finished finding.

As of 2026-11-09T00:00:00+00:00, the sponsor is University of Parma and the study title points to a simple idea with practical appeal: testing whether a (poly)phenol-rich diet can help improve cardiometabolic health. For everyday readers, cardiometabolic health means the overlap of heart and metabolic health, including risk tied to blood vessels and how the body handles energy.

This record describes a study and its registry status; study outcomes require posted results.

How the trial is set up

The study is RANDOMIZED and split into four arm groups: Metabotype X, Treatment; Metabotype X, Control; Metabotype Y, Treatment; and Metabotype Y, Control. That design suggests the researchers are comparing treatment and control paths while also separating participants by metabotype, a label the record uses for different aggregate phenolic patterns.

The interventions are Personalized Dietary Plan, Oral (Poly)phenol Challenge Test (OPCT), and General Dietary Advice. The Personalized Dietary Plan is assigned to the two treatment groups, while OPCT appears across all four groups and General Dietary Advice is tied to the control groups. In plain terms, the study is not just asking whether diet matters, but whether a more tailored diet approach behaves differently from general advice.

Assessing the effect of a (poly)phenol-rich diet on 10-year cardiovascular risk: Systematic Coronary Risk Estimation

Who it is designed to study

The primary outcomes are aimed at two age ranges. One measure uses Systematic Coronary Risk Estimation for volunteers aged between 40 and 69 years, and the other uses Systematic Coronary Risk Estimation-Older Persons for volunteers aged between 70 and 89 years.

Both outcomes are scheduled for Visit 3 after 8 weeks and Visit 5 after 24 weeks from the beginning of the study. That gives the trial a short-to-medium timeline for tracking whether the diet-related approach changes estimated 10-year cardiovascular risk in the groups it follows.

The record lists the primary_completion_date as 2027-02-28 and the primary_completion_type as ESTIMATED. Until then, the most important fact is that the study remains in recruitment and has not yet posted results.

Why this matters now

This registry observation fits a broader Obesity & Metabolic theme because it tests a nutrition-based approach to risk, rather than a drug or device. Readers watching this area may find it useful alongside other recruiting or active studies in the same special event.

For now, the cautious takeaway is straightforward: the study is open, the design is structured, and the outcomes are still ahead. The idea under test is not a promise, but a question the investigators are trying to answer with a randomized comparison.

Registry observation: Precision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)Phenols (NA, RECRUITING)